These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32266774)

  • 1. An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; Zelen CM
    Int Wound J; 2020 Aug; 17(4):966-973. PubMed ID: 32266774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a novel purified reconstituted bilayer matrix for treatment of chronic diabetic foot ulcers: a retrospective case series.
    Isaac AL; Tritto M
    Wounds; 2023 Jan; 35(1):E29-E34. PubMed ID: 36749995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2022 Aug; 19(5):1197-1209. PubMed ID: 35001559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
    Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
    J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot Study to Evaluate the Effects of Perfusion-decellularized Porcine Hepatic-derived Wound Matrix on Difficult-to-heal Diabetic Foot Ulcers.
    Fridman R; Engelhardt J
    Wounds; 2017 Oct; 29(10):317-323. PubMed ID: 29091040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers.
    Yao M; Hasturk H; Kantarci A; Gu G; Garcia-Lavin S; Fabbi M; Park N; Hayashi H; Attala K; French MA; Driver VR
    Int Wound J; 2014 Dec; 11(6):586-93. PubMed ID: 23163982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ease of use, safety, and efficacy of integra bilayer wound matrix in the treatment of diabetic foot ulcers in an outpatient clinical setting: a prospective pilot study.
    Yao M; Attalla K; Ren Y; French MA; Driver VR
    J Am Podiatr Med Assoc; 2013; 103(4):274-80. PubMed ID: 23878379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter retrospective study comparing a polylactic acid CAMP with intact fish skin graft or a collagen dressing in the management of diabetic foot ulcers and venous leg ulcers.
    Liden BA; Liu T; Regulski M; Foster M; DeLeon R; Palazzi G; Ramirez-GarciaLuna JL
    Wounds; 2024 Sep; 36(9):297-302. PubMed ID: 39378347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
    Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
    Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial.
    Lavery LA; Fulmer J; Shebetka KA; Regulski M; Vayser D; Fried D; Kashefsky H; Owings TM; Nadarajah J;
    Int Wound J; 2014 Oct; 11(5):554-60. PubMed ID: 25048468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Hard-to-heal Diabetic Foot Ulcers With a Hepatic-derived Wound Matrix.
    Fridman R; Rafat P; Van Gils CC; Horn D; Vayser D; Lambert JC
    Wounds; 2020 Sep; 32(9):244-252. PubMed ID: 32813669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre clinical trial evaluating the outcomes of two application regimens of a unique keratin-based graft in the treatment of Wagner grade one non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Carter MJ; Hanft J; Surprenant M; Isaac AL; Zelen CM
    Int Wound J; 2024 Sep; 21(9):e70029. PubMed ID: 39245798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
    Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
    J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.